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The prevalence of common oral diseases, such as dental caries, periodontal dis-
eases and oral candidiasis remains high in the general population. Various pre-
ventive strategies have been proposed and included in national health programs 
promoting oral health. Interest in probiotics in light of oral health has gradually 
evolved as attractive means in prevention of oral infectious diseases. The aim of 
the present review is to outline the current evidence on the role of probiotic spe-
cies on oral health parameters and their benefi cial role in contributing to healthier 
oral environment.
INTRODUCTION
Oral health is a vital component of health. World 
Health Organization defi nes it as a state of being 
free from chronic mouth and facial pain, oral and 
throat cancer, oral sores, birth defects such as cleft 
lip and palate, periodontal (gum) disease, tooth de-
cay and tooth loss, and other diseases and disorders 
that affect the oral cavity.1 Global health preventive 
programs adopted worldwide have substantially 
contributed to reducing the extent and the severity 
of common oral diseases. Yet the prevalence of peri-
odontal diseases and caries, both having microbial 
components in their etiology, remain high. Caries 
affects practically everyone in the global population 
at some stages of life while 15 – 35% of the adult 
population in industrialized countries is estimated 
to have periodontitis.2
The role of host microbiota in individual’s health 
has been developing as a concept for more than 
a century. In the early 1900s, Bond Stow empha-
sized the signifi cance of Lactobacillus bulgaricus 
on autointoxication and its importance on balanc-
ing gut health.3 The theory of Nobel laureate Ilya 
Metchnikoff (Fig. 1), that “we fi ght microbe with 
microbe”4) has attracted numerous followers who 
have presented clinical evidence on the role of 
lactic acid bacteria administration and their con-
trol on autointoxication-related mental conditions. 
However, this theory has been seriously discredited 
for several decades by famous supporters from the 
United States like Alvarez and Donaldson who 
‘debunked’ autointoxication.5 The rapid scientifi c 
and technological advances in the new millennium 
have led to paradigm shift in understanding the 
relevance of entire body microbiome to human 
health and well-being. The role of benefi cial healthy 
bacteria has been related to numerous pathological 
conditions of the gastrointestinal tract, skin, respi-
ratory system and even mental health. Probiotics, 
which exert their health effect when digested in 
certain quantities, are able to promote health either 
directly or through their infl uence on other gut 
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microbes.6 The main mode of probiotic activity is 
ascribed to their infl uence on systemic cytokines, 
oxidative stress, and infl ammatory markers upon 
oral consumption.7
Probiotics and their role on oral health has been 
proposed at the turn of the century and the reader 
is referred to two comprehensive review articles 
published in 2005 outlining the main scope and 
clinical relevance of healthy bacteria in the mouth.8,9 
The aim of the present review was to outline and 
discuss the advances in probiotic research in rela-
tion to prevention and management of common 
oral diseases. Table 1 lists probiotic species used 
in clinical trials in the fi eld of dentistry.
PROBIOTICS AND DENTAL CARIES
Dental caries, although preventable, remains one 
of the most prevalent oral diseases in children and 
adults worldwide. Fernando et al.10 have suggested 
that dental caries in children could be a result of 
possible interaction of risk factors such as maternal 
characteristics, environment, child’s individual fac-
tors and epigenetics. Sugar and sugar-rich diet have 
been the main culprits for the development of carious 
lesions. A shift from the caries-promoting bacterium 
Streptococcus mutans only towards a more complex 
acid-tolerant consortium of oral bacteria leading to 
disease has been adopted lately. Molecular micro-
biological methods have shown that even with a 
sugar-rich diet a much broader spectrum of acidogenic 
microbes is found in dental biofi lm.11 Prevention 
of tooth decay by solely targeting S. mutans or by 
mainly limiting sugar intake is easily doomed to be 
ineffi cient in affecting disease progression. A more 
complex multidisciplinary approach including, for 
example, control of biofi lm composition, control 
of dietary sugars in oral biofi lm, and prolonged 
fl uoride release, may be needed for caries control. 
Bacteriotherapy has emerged as such an alternative 
preventive measure which could target and tailor 
Figure 1. Ilya Metchnikoff, who laid the foundations of modern probiotics, and Stamen Grigorov, who isolated 
Lactobacillus bulgaricus, the main yoghurt starter.
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oral biofi lm composition towards healthier microbial 
community. The use of in vitro and in silico biofi lm 
models has allowed studies on bacteria in their 
similar-to-natural habitat, and respective changes in 
their habitat, to be investigated in more detail thus 
leading to more reliable outcomes.12 
A primary requirement for a probiotic candidate 
is for that agent to establish itself in the respec-
tive environment. Our in vitro studies have shown 
that the probiotic Lactobacillus rhamnosus GG 
(LGG) could grow in dual- and multi-species oral 
biofi lms affecting to various degrees the number 
of S. sanguinis and S. mutans in 4- and 2-species 
biofi lm models, respectively.13 This integration of 
extrinsic probiotic species in oral community could 
be attributed to good adhesion properties and/or 
competition for binding sites with other species, 
as well as inhibitory activity against other mem-
bers of the oral biofi lm. Teanpaisan and coworkers 
have shown in vitro that caries pathogens could 
be effectively inhibited by oral lactobacilli with 
Lactobacillus SD1-SD6 possessing the strongest 
inhibitory effect against S. mutans and S. sobrinus.14 
LGG in different carriers, such as milk and cheese, 
has shown caries reducing effect in children.15,16 
Caries preventive effect of LGG could be due to 
improved salivary buffering capacity and reduction 
of S. mutans counts.17 Salivary buffering capacity 
has also been observed to increase when healthy 
volunteers were given a probiotic tablet containing 
L. salivarius, thus allowing the authors to conclude 
that probiotic administration may lead to increased 
resistance to caries risk factors.18 Caries preventive 
effect of probiotics correlates with the time of their 
administration. Stensson et al.19 reported reduced 
caries prevalence and gingivitis score in primary 
dentition in 9-year-olds when the children had 
been given L. reuteri from birth and through their 
fi rst year of life. Bifi dobacterium animalis subsp. 
lactis BB-12 and L. paracasei F19, conversely, 
had no effect on caries occurrence if provided in 
infancy.20,21 Extrinsic probiotics rarely do establish 
Table 1. Probiotic species used in clinical trials to target oral diseases/conditions
Species Condition Number ofsubjects
Vehicle of
administration Reference
L. rhamnosus Caries prevention 261 milk Rodriguez et al. 2016
L. reuteri Early carious lesions 36 tablet Keller at al. 2014
B. lactis Caries prevention 106 tablet Taipale et al. 2012
L. rhamnosus Root caries 160 milk Petersson et al. 2011
L. reuteri Chronic periodontitis 40 lozenge Tekce et al. 2015
L. reuteri Gingivitis 40 tablet Iniesta et al. 2012
L. salivarius Halitosis 20 tablet Iwamoto et al. 2010
L.salivarius Prevention of periodontitis 66 tablet Shimauchi et al. 2008
B. longum, S. 
thermophilus,
L. bulgaricus
Candida-associated sto-
matitis 65 mixture Li et al. 2014
L. rhamnosus Candida prevention 276 cheese Hatakka et al. 2007
L. brevis Halitosis 20 lozenge Marchetti et al. 2015
L. reuteri Halitosis 25 chewing gum Keller et al. 2012
L. reuteri Alteration to oral micro-biotia 44 lozenge Romani Vestman et al. 2015
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themselves in the mouth, but although transient, 
their presence may affect re-colonization of mutans 
streptococci after full-mouth disinfection as shown 
with L. reuteri.22,23 Except for their caries preventive 
potential, L. reuteri and L. rhamnosus have been 
tested to affect pre-existing carious lesions. No 
adverse effects were detected by administering L. 
reuteri but its intake insubstantially affected initial 
carious lesions.24 However, a different outcome with 
reversal of primary root caries in healthy adults 
has been achieved with milk supplemented with 
L. rhamnosusmech and fl uoride.25
To conclude, the effect of probiotics on dental 
caries remains species-dependent and results differ 
between studies. More robust randomized clinical 
trials are needed before a universal probiotic strain, 
or possibly a combination of species, is found for 
the purposes of caries prevention and control.
PROBIOTICS AND PERIODONTAL DISEASES
Periodontal diseases including gingivitis and peri-
odontitis originate in the presence of susceptible host 
challenged by the burden of pathogens in oral biofi lm. 
They are clinically manifested by bleeding on prob-
ing, swelling, color alterations, pain, and in advanced 
stages tooth mobility is the leading symptom. Scaling 
and root planing and deep pocket debridement are 
primary treatment strategies which allow signifi cant 
reduction of aggressive periopathogens. Although 
removing plaque by mechanical surface instrumen-
tation is reliable and effi cient treatment modality, 
the pocket re-colonization is highly unpredictable. 
In this regard, probiotics or benefi cial microbes 
may fi nd their place in tailoring treatment outcome 
after routine periodontal treatment. The periodontal 
pathogens in supra- and subgingival biofi lm could 
be substantially reduced after probiotic lactobacilli 
administration as demonstrated by Mayanagi et al.26 
In subjects who have been clinically diagnosed 
with mild or moderate gingivitis probiotic adminis-
tration is shown to decrease the volume of gingival 
crevicular fl uid and bleeding on probing; clinical 
parameters such as gingival and plaque indices 
have also been positively affected.27,28 The observed 
changes are related to the reduced concentrations 
of infl ammatory cytokines such as TNF-α and IL-8, 
caused by probiotics. The reduction in the number of 
periodontal pathogens after L. reuteri administration 
unequivocally contributed to improved parameters 
of gingival health.29 Experimental gingivitis in 
healthy subjects, depending on the probiotic spe-
cies tested, may show favorable outcome in terms 
of lower amount of gingival crevicular fl uid, less 
bleeding on probing, lower elastase and MMP-3 
activities.30,31 However, daily intake of probiotic 
lozenges was not a winning strategy for experimen-
tal gingivitis when seven infl ammatory mediators 
were measured.32
The most commonly used probiotic species in 
chronic periodontitis patients so far is L. reuteri. 
It has been a useful adjunct to scaling and root 
planing when given as a lozenge once or twice 
daily. Lowering plaque index, gingival index, prob-
ing pocket depth and bleeding were the observed 
treatment outcomes.33,34 Again, the anticipated 
mechanisms of probiotic activity were associated 
with reduced numbers of periodontal pathogens, 
such as Porphyromonas gingivalis, and lower con-
centrations of TNF-α, IL-1β and IL-17 in gingival 
crevicular fl uid.35,36
An emerging problem with the growing number 
of dental implants placed in general population is 
the occurrence of peri-implantitis and peri-implant 
mucositis which in their origin also are microbe-
mediated. Attempt to use probiotics to combat such 
treatment complications has also been made. How-
ever, in these cases there is no clinical evidence 
to justify the use of probiotic supplements in ad-
dition to mechanical debridement and oral hygiene 
reinforcement.37 As regards peri-implantitis, more 
studies with probiotic supplementation are indeed 
called for. In general, scientifi c evidence on pro-
biotics vs. periodontal diseases still remains weak.
PROBIOTICS AND ORAL CANDIDA INFECTIONS
Another reasonably well explored fi eld of probiotic 
applications is the chronic Candia infections of the 
soft tissues in the mouth. Candida species most 
commonly isolated from the oral cavity include C. 
albicans, C. glabrata, C. krusei, C. parapsilosis 
and C. tropicalis. The growing antifungal resis-
tance is becoming a serious problem worldwide 
and new strategies to combat pathogenic fungi in 
biofi lm structures have been sought. In vitro stud-
ies have shown various inhibitory activity against 
oral Candida by different commercially available 
probiotic lactobacilli, with strongest inhibitory effect 
observed with LGG.38 In an animal model study S. 
salivarius K12, a nonpathogenic commensal oral 
probiotic microorganism, signifi cantly protected 
the mice from severe candidiasis by inhibiting the 
process of invasion of C. albicans into mucous 
surfaces or its adhesion to denture acrylic resins by 
mechanisms not associated with the antimicrobial 
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activity of the bacteriocin.39 Lactobacillus casei and 
Bifi dobacterium breve in yoghurt drink positively 
affect secretory IgA levels in saliva and signifi cant 
reduction in Candida and non-Candida species has 
been observed in the oral cavity of elderly.40 Frail 
elderly people living in nursing homes are among 
individuals highly susceptible to fungal infections. A 
L. reuteri lozenge given twice a day for 12 weeks 
led to a signifi cant reduction of Candida counts 
in the oral cavities of elderly, although no notable 
effects on plaque index and bleeding on probing 
were defi ned.41 Similarly, probiotic combination 
of Propionibacter freudenreichii and LGG given in 
cheese reduced the risk for high salivary Candida 
counts by 75% compared with placebo cheese in 
a short-term intervention study on the elderly.42 
However, the true value of probiotics in controlling 
oral Candida is still an open question.
PROBIOTICS AND HALITOSIS
Halitosis, or the unpleasant odour exhaled through 
the mouth, is a multifactorial condition which may 
have oral and/or non-oral origins.43,44 It is mainly 
attributed to biofi lm accumulation on the dorsum 
of the tongue, the interdental spaces, and chronic 
infl ammatory diseases of the periodontium. The 
prevalence of halitosis varies with estimated range 
between 22% to 50% in populations.45-49 
Volatile sulphur compounds (VSC) like hydrogen 
sulphide and methyl mercaptans and other addi-
tional odours such as indole, skatole, putrescine 
and cadaverine are byproducts of food degradation 
by halitosis-producing microorganisms.50 A rich 
source of VSC is the periodontal pocket densely 
populated by Fusobacterium nucleatum, P. gingi-
valis, Prevotella intermedia, Tannerella forsythia, 
Treponema denticola, Micromonas micros, Campy-
lobacter rectus, and Eikenella corrodens.51-53 The 
intensity of clinical bad breath has been correlated 
directly to periodontal health status.54 Neverthe-
less, true evidence of such relationship has been 
questionable54,55, and tongue microbiota may play a 
greater role in terms of oral malodor in comparison 
to subgingival bacteria.56-58 Halitosis could also be 
associated with dietary habits and consumption of 
foods like garlic, onions or spiced foods is a well 
understood reason for this. Certain diseases, such 
as diabetes and uremia, and medications could also 
contribute to bad breath.59-61
Halitosis affects to various degrees key aspects 
of person’s quality of life refl ecting in social rela-
tionships and emotional well-being. Treatment of 
halitosis is achievable once its etiology is properly 
diagnosed. Self-care products such as chewing gums, 
mouthwashes, mouth sprays and toothpastes can 
mask temporarily the unpleasant odor and improve 
the satisfaction of the individual. However, the 
emphasis remains on professional treatment and 
strategies at reduction and/or elimination of VSC 
producing microorganisms.
Burton et al.62 were the fi rst to address the po-
tential of oral probiotics in reduction of halitosis. 
By administering S. salivarius K12 in lozenges 
after initial chlorhexidine rinse, eight out of 13 
healthy individuals maintained reduced breath 
levels of VSCs for at least 2 weeks. Pre-emptive 
colonization of the oral cavity with competitive 
commensal bacteria following mechanical and 
chemical pretreatment has been the aim of Burton 
at al.63 when combating halitosis with S. salivarius 
K12. Additionally, salivaricin production by pro-
biotic species could cross-stimulate salivaricin 
production by other pre-existing members of the 
host microbiota, thus establishing lower levels of 
VSC. Inhibitory activity of S. salivarius K12 on 
Gram-positive species involved in halitosis is an-
other mode of activity to be utilized when target-
ing bad breath.64 A cross-over trial including 23 
participants has shown L. salivarius WB21 to have 
a positive effect on oral malodor parameters by 
using organoleptic test score.65 Moreover, the same 
species has shown benefi cial effects on bleeding on 
probing from the periodontal pocket. Administering 
probiotics with chewing gums could also reduce 
bacteria that produce malodorous compounds other 
than VSCs as demonstrated by Keller et al.66 Af-
ter 14 days of treatment, the organoleptic scores 
were signifi cantly lower in the L. reuteri group 
compared with placebo. In vitro testing of yogurt 
starter S. thermophilus could reduce generation of 
VSCs by P. gingivialis possibly by suppressing its 
growth, and the whole bacteria and the spent culture 
medium of S. thermophilus reduced emission of 
VSCs.67 A well-studied probiotic species L. brevis 
CD2, however, showed no effect on halitosis after 
14-day treatment in a randomized, double-blind 
placebo-controlled clinical trial.68 However, although 
potentially promising, the results from the above 
mentioned studies there still is no sound evidence 
to support recommendation of probiotics for the 
treatment of halitosis. 
 CONCLUSION
Evidence of benefi cial effects of probiotics on 
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oral health is accumulating. In general, the grow-
ing population awareness and demand for healthy 
living inevitably leads to broader availability of 
health-promoting foods on the market. In this fi eld 
probiotics have become fashionable among the 
public and are marketed as one of the key elements 
in well-balanced general health. As here discussed, 
most oral health effects of probiotics have been 
observed after administration of strains which are 
not natural members of oral microbiota. Possibly 
a more attractive and reliable probiotic might be 
found among species which are natural members in 
the host microbiome. Screening of such probiotic 
candidates in human oral bacterial populations is 
ongoing with some evidence already available.69 
Further, multi-center clinical trials with enough 
statistical power, and the use of high-throughput 
analytical tools, are needed for true evidence be-
fore the role of probiotics on oral health can be 
established and their use justifi ed. Currently the 
evidence yet remains weak.
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Распространение таких наиболее часто встречающихся стоматологических 
заболеваний как зубной кариес, пародонтоз и оральный кандидоз остаётся 
по-прежнему высоким среди населения. Большое количество разных страте-
гий для профилактики данных заболеваний были предложены и включены в 
национальные программы здравоохранения, нацеленные на стоматологиче-
ское здоровье. Интерес к пробиотикам в свете стоматологического здоровья 
постепенно возрос в качестве привлекательного средства для профилактики 
стоматологических инфекционных заболеваний. Целью настоящего обозре-
ния является рассмотрение современных доказательств о роли  пробиоти-
ческих штаммов в отношении параметров стоматологического здоровья и их 
полезной роли в отношении более здоровой  среды полости рта
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